{"id":"https://openalex.org/W2140131270","doi":"https://doi.org/10.1212/wnl.56.2.172","title":"Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy","display_name":"Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy","publication_year":2001,"publication_date":"2001-01-23","ids":{"openalex":"https://openalex.org/W2140131270","doi":"https://doi.org/10.1212/wnl.56.2.172","mag":"2140131270","pmid":"https://pubmed.ncbi.nlm.nih.gov/11160951"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.56.2.172","doi":"https://doi.org/10.1212/wnl.56.2.172","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.56.2.172","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2140131270"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085356343","display_name":"Victor Biton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. Biton","raw_affiliation_strings":["From the Arkansas Epilepsy Program (Dr. Biton), Little Rock; Neurology and Epileptology (Dr. Mirza), Bridgeton, and Comprehensive Epilepsy Care Center (Dr. Montouris), St. Louis, MO; and Glaxo Wellcome (Dr. Barrett, A. Vuong, and A.E. Hammer), Research Triangle Park, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Arkansas Epilepsy Program (Dr. Biton), Little Rock; Neurology and Epileptology (Dr. Mirza), Bridgeton, and Comprehensive Epilepsy Care Center (Dr. Montouris), St. Louis, MO; and Glaxo Wellcome (Dr. Barrett, A. Vuong, and A.E. Hammer), Research Triangle Park, NC","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088203313","display_name":"Waqar Mirza","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W. Mirza","raw_affiliation_strings":["From the Arkansas Epilepsy Program (Dr. Biton), Little Rock; Neurology and Epileptology (Dr. Mirza), Bridgeton, and Comprehensive Epilepsy Care Center (Dr. Montouris), St. Louis, MO; and Glaxo Wellcome (Dr. Barrett, A. Vuong, and A.E. Hammer), Research Triangle Park, NC","Innsbruck, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Arkansas Epilepsy Program (Dr. Biton), Little Rock; Neurology and Epileptology (Dr. Mirza), Bridgeton, and Comprehensive Epilepsy Care Center (Dr. Montouris), St. Louis, MO; and Glaxo Wellcome (Dr. Barrett, A. Vuong, and A.E. Hammer), Research Triangle Park, NC","institution_ids":[]},{"raw_affiliation_string":"Innsbruck, Austria","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085037662","display_name":"Georgia Montouris","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Montouris","raw_affiliation_strings":["From the Arkansas Epilepsy Program (Dr. Biton), Little Rock; Neurology and Epileptology (Dr. Mirza), Bridgeton, and Comprehensive Epilepsy Care Center (Dr. Montouris), St. Louis, MO; and Glaxo Wellcome (Dr. Barrett, A. Vuong, and A.E. Hammer), Research Triangle Park, NC","Innsbruck, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Arkansas Epilepsy Program (Dr. Biton), Little Rock; Neurology and Epileptology (Dr. Mirza), Bridgeton, and Comprehensive Epilepsy Care Center (Dr. Montouris), St. Louis, MO; and Glaxo Wellcome (Dr. Barrett, A. Vuong, and A.E. Hammer), Research Triangle Park, NC","institution_ids":[]},{"raw_affiliation_string":"Innsbruck, Austria","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109878814","display_name":"A. Vuong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Vuong","raw_affiliation_strings":["From the Arkansas Epilepsy Program (Dr. Biton), Little Rock; Neurology and Epileptology (Dr. Mirza), Bridgeton, and Comprehensive Epilepsy Care Center (Dr. Montouris), St. Louis, MO; and Glaxo Wellcome (Dr. Barrett, A. Vuong, and A.E. Hammer), Research Triangle Park, NC","Innsbruck, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Arkansas Epilepsy Program (Dr. Biton), Little Rock; Neurology and Epileptology (Dr. Mirza), Bridgeton, and Comprehensive Epilepsy Care Center (Dr. Montouris), St. Louis, MO; and Glaxo Wellcome (Dr. Barrett, A. Vuong, and A.E. Hammer), Research Triangle Park, NC","institution_ids":[]},{"raw_affiliation_string":"Innsbruck, Austria","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072719649","display_name":"Anne E. Hammer","orcid":"https://orcid.org/0000-0003-0217-3848","observed_orcids":["https://orcid.org/0000-0003-0217-3848"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A.E. Hammer","raw_affiliation_strings":["From the Arkansas Epilepsy Program (Dr. Biton), Little Rock; Neurology and Epileptology (Dr. Mirza), Bridgeton, and Comprehensive Epilepsy Care Center (Dr. Montouris), St. Louis, MO; and Glaxo Wellcome (Dr. Barrett, A. Vuong, and A.E. Hammer), Research Triangle Park, NC","Innsbruck, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Arkansas Epilepsy Program (Dr. Biton), Little Rock; Neurology and Epileptology (Dr. Mirza), Bridgeton, and Comprehensive Epilepsy Care Center (Dr. Montouris), St. Louis, MO; and Glaxo Wellcome (Dr. Barrett, A. Vuong, and A.E. Hammer), Research Triangle Park, NC","institution_ids":[]},{"raw_affiliation_string":"Innsbruck, Austria","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5107560946","display_name":"Pamela S. Barrett","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P.S. Barrett","raw_affiliation_strings":["From the Arkansas Epilepsy Program (Dr. Biton), Little Rock; Neurology and Epileptology (Dr. Mirza), Bridgeton, and Comprehensive Epilepsy Care Center (Dr. Montouris), St. Louis, MO; and Glaxo Wellcome (Dr. Barrett, A. Vuong, and A.E. Hammer), Research Triangle Park, NC","Innsbruck, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Arkansas Epilepsy Program (Dr. Biton), Little Rock; Neurology and Epileptology (Dr. Mirza), Bridgeton, and Comprehensive Epilepsy Care Center (Dr. Montouris), St. Louis, MO; and Glaxo Wellcome (Dr. Barrett, A. Vuong, and A.E. Hammer), Research Triangle Park, NC","institution_ids":[]},{"raw_affiliation_string":"Innsbruck, Austria","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":13.894,"has_fulltext":false,"cited_by_count":235,"citation_normalized_percentile":{"value":0.99356664,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"56","issue":"2","first_page":"172","last_page":"177"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9423999786376953,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9423999786376953,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.05209999904036522,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12267","display_name":"Diet and metabolism studies","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/valproic-acid","display_name":"valproic acid","score":0.8989999890327454},{"id":"https://openalex.org/keywords/lamotrigine","display_name":"lamotrigine","score":0.9900000095367432},{"id":"https://openalex.org/keywords/divalproex-sodium","display_name":"divalproex sodium","score":0.7860000133514404},{"id":"https://openalex.org/keywords/epilepsy","display_name":"epilepsy","score":0.6470000147819519},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.8619999885559082},{"id":"https://openalex.org/keywords/antiepileptic-monotherapy","display_name":"antiepileptic drug monotherapy","score":0.7409999966621399},{"id":"https://openalex.org/keywords/seizure-frequency","display_name":"seizure frequency","score":0.5920000076293945},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6320000290870667},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.8240000009536743},{"id":"https://openalex.org/keywords/focal-seizures","display_name":"focal seizures","score":0.5929999947547913},{"id":"https://openalex.org/keywords/generalized-seizures","display_name":"generalized seizures","score":0.9929999709129333}],"concepts":[{"id":"https://openalex.org/C2778802184","wikidata":"https://www.wikidata.org/wiki/Q410346","display_name":"Lamotrigine","level":3,"score":0.9876381158828735},{"id":"https://openalex.org/C2777172819","wikidata":"https://www.wikidata.org/wiki/Q240642","display_name":"Valproic Acid","level":3,"score":0.6861384510993958},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.6620675325393677},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6302676200866699},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.5432021617889404},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5248401761054993},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4165377616882324},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39206379652023315},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3900083899497986},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3763430714607239},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.10387024283409119}],"mesh":[{"descriptor_ui":"D000077213","descriptor_name":"Lamotrigine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014635","descriptor_name":"Valproic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1212/wnl.56.2.172","doi":"https://doi.org/10.1212/wnl.56.2.172","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.56.2.172","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},{"id":"pmid:11160951","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11160951","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W1747136232","https://openalex.org/W1964115141","https://openalex.org/W1964227153","https://openalex.org/W1974489840","https://openalex.org/W1976447502","https://openalex.org/W1978106454","https://openalex.org/W1979819746","https://openalex.org/W1983699580","https://openalex.org/W1985372163","https://openalex.org/W1990895339","https://openalex.org/W1996848139","https://openalex.org/W1998319716","https://openalex.org/W1998338808","https://openalex.org/W1999772609","https://openalex.org/W2014261444","https://openalex.org/W2014306890","https://openalex.org/W2014996233","https://openalex.org/W2016909246","https://openalex.org/W2020282477","https://openalex.org/W2022933598","https://openalex.org/W2023162470","https://openalex.org/W2046700024","https://openalex.org/W2050169733","https://openalex.org/W2050899593","https://openalex.org/W2092413298","https://openalex.org/W2117449343","https://openalex.org/W2120557435","https://openalex.org/W2139454197","https://openalex.org/W2142602157","https://openalex.org/W2157274804","https://openalex.org/W2161001082","https://openalex.org/W2338906118","https://openalex.org/W2357554713"],"related_works":["https://openalex.org/W2241995017","https://openalex.org/W1976885468","https://openalex.org/W2033203456","https://openalex.org/W2022933598","https://openalex.org/W1974489840","https://openalex.org/W2163597003","https://openalex.org/W2886780391","https://openalex.org/W2164724677","https://openalex.org/W4250235103","https://openalex.org/W1668406053"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"compare":[2],"the":[3,101,113,138,148,195,204,216,225,257],"incidence":[4],"and":[5,32,45,58,90,93,181,219,254],"magnitude":[6],"of":[7,141,153,176,189,260,266],"change":[8,87],"in":[9,19,127,134,161,178],"body":[10],"weight":[11,131,143,156,236],"associated":[12,232,243],"with":[13,21,28,50,77,233,244,264],"lamotrigine":[14,102,179,217,239,261,268],"or":[15,72,79,83],"divalproex":[16],"sodium":[17],"monotherapy":[18,230],"patients":[20,69,105,117,136,177],"epilepsy.":[22],"METHODS:":[23],"A":[24],"randomized,":[25],"double-blind":[26],"study":[27,205],"8-week":[29],"escalation":[30],"phase":[31,35],"24-week":[33],"maintenance":[34,39],"was":[36,41,88,158,192,210,231,246,262],"conducted.":[37],"Target":[38],"dosage":[40],"200":[42],"mg/day":[43,56],"(lamotrigine)":[44,57],"20":[46],"mg/kg/day":[47,62],"(valproic":[48],"acid),":[49],"adjustment":[51],"from":[52,203],"100":[53],"to":[54,60,145,201,207,270],"500":[55],"10":[59,249],"60":[61],"(valproate)":[63],"based":[64],"on":[65],"investigators'":[66],"judgment.":[67],"Eligible":[68],"were":[70,95,110,122,185],">":[71],"=":[73],"12":[74],"years":[75],"old":[76],"new-onset":[78],"previously":[80],"diagnosed":[81],"partial":[82],"generalized":[84],"seizures.":[85],"Weight":[86,124,241],"primary":[89],"seizure":[91],"frequency":[92,188],"tolerance":[94],"secondary":[96],"outcome":[97],"measures.":[98],"RESULTS:":[99],"For":[100],"group,":[103,115],"65":[104],"(mean":[106,118],"age":[107,119],"34.5":[108],"years)":[109,121],"investigated;":[111],"for":[112,215,224],"valproate":[114,182,226,245],"68":[116],"30.1":[120],"investigated.":[123],"remained":[125],"stable":[126],"lamotrigine-treated":[128,168],"patients.":[129,173],"Significant":[130],"gain":[132,157,237,242],"occurred":[133],"valproate-treated":[135,162],"by":[137],"10th":[139],"week":[140],"treatment;":[142],"continued":[144,255],"increase":[146],"throughout":[147,256],"study.":[149,258],"After":[150],"32":[151],"weeks":[152,250],"treatment,":[154],"mean":[155],"significantly":[159,234],"higher":[160],"(12.8":[163],"+/-":[164,170,212,221],"9.3":[165],"lb)":[166,172],"than":[167,238],"(1.3":[169],"11.9":[171],"Similar":[174],"proportions":[175],"(29%)":[180],"(26%)":[183],"groups":[184],"seizure-free.":[186],"Overall":[187],"adverse":[190,208],"events":[191,209],"similar":[193],"between":[194],"two":[196],"treatment":[197],"groups.":[198],"Mean":[199],"time":[200],"withdrawal":[202],"due":[206],"103":[211],"70":[213],"days":[214,223],"group":[218],"79":[220],"48":[222],"group.":[227],"CONCLUSION:":[228],"Valproate":[229],"greater":[235],"monotherapy.":[240],"significant":[247],"within":[248],"after":[251],"initiating":[252],"therapy":[253],"Efficacy":[259],"comparable":[263],"that":[265],"valproate;":[267],"tended":[269],"be":[271],"better":[272],"tolerated.":[273]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":8},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":12},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}